@zecs the only phase I/II trial that has been going for any length of time was the burns trial. this was investigator sponsored and therefore beyond RCE 's control. phase I dosing trial for IV dosing has not long concluded and is critical for establishing safety but is not indication specific. each indication will likely need a specific phase II and III trial. the Foot ulcer trial and the uTi trial are all progressing to the next phase in a timely manner. what were your expectations? drugs on average take 10 years and a billion dollars to get approved. RCE is well short of that
Ann: R327 added to WHO List of Antibacterial Products, page-17
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
59.5¢ |
Change
0.005(0.85%) |
Mkt cap ! $120.3M | |||
| Open | High | Low | Value | Volume |
| 59.0¢ | 59.5¢ | 59.0¢ | $21.66K | 36.48K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 12094 | 58.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 59.5¢ | 12402 | 3 |
View Market Depth
| Last trade - 10.43am 20/06/2024 (20 minute delay) ? |
| RCE (ASX) Chart |